Press Releases Filter Filter Results Year 2026 (2) 2025 (3) 2024 (5) 2023 (5) 2022 (23) 2021 (17) 2020 (37) 2019 (35) 2018 (23) 2017 (24) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) April 4, 2019 Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval March 18, 2019 Impella RP Post-Approval Study Data Presented at ACC 2019 March 14, 2019 Benefits of Heart Recovery with Impella Showcased at ACC 2019 February 20, 2019 $100 Million Invested in Clinical Research for Impella January 31, 2019 Abiomed Announces Q3 FY 2019 Record Revenue of $201 Million, up 30% over Prior Year January 10, 2019 Abiomed Third Quarter Fiscal 2019 Earnings and Conference Call Notification January 7, 2019 Abiomed Announces Preliminary Q3 FY 2019 Revenue of $201 Million, Up 30% Over Prior Year and Increases Full Year Guidance December 28, 2018 Abiomed to Present at the 37th Annual J.P. Morgan Healthcare Conference November 11, 2018 FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible November 2, 2018 Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY November 1, 2018 Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million, up 37% Over Prior Year October 11, 2018 Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification September 24, 2018 Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival September 19, 2018 Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018 July 26, 2018 Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year … 8 9 10 11 …
